+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Leflunomide"

Leflunomide Tablets Market - Global Forecast to 2030 - Product Thumbnail Image

Leflunomide Tablets Market - Global Forecast to 2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Rheumatology Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Rheumatology Therapeutics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 196 Pages
  • Global
From
Rheumatoid Arthritis Drugs Market Report 2025 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Prescription Orthopedic Drugs Market Report 2025 - Product Thumbnail Image

Prescription Orthopedic Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Polymyalgia Rheumatica Market Report 2025 - Product Thumbnail Image

Polymyalgia Rheumatica Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
Psoriatic Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
From
From
From
From
  • 17 Results (Page 1 of 1)
Loading Indicator

Leflunomide is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriatic arthritis, and polyarticular juvenile idiopathic arthritis. It works by blocking the production of certain proteins that cause inflammation and joint damage. It is usually taken in pill form, but can also be administered as an injection. Leflunomide is a relatively new drug, having been approved by the US Food and Drug Administration in 1998. It is generally well-tolerated, with few side effects. Common side effects include nausea, diarrhea, and headache. The leflunomide market is growing, as more people are being diagnosed with immune disorders. It is a competitive market, with several companies offering their own versions of the drug. Companies in the leflunomide market include Sanofi, Pfizer, Merck, and AbbVie. Show Less Read more